These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 38720248)

  • 1. Need for informed providers: exploring LA-PrEP access in focus groups with PrEP-indicated communities in Baltimore, Maryland.
    Kaptchuk RP; Thomas AM; Dhir AM; Solomon SS; Clipman SJ
    BMC Public Health; 2024 May; 24(1):1258. PubMed ID: 38720248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPTN 083-02: factors influencing adherence to injectable PrEP and retention in an injectable PrEP study.
    Psaros C; Goodman GR; Lee JS; Rice W; Kelley CF; Oyedele T; Coelho LE; Phanuphak N; Singh Y; Middelkoop K; Griffith S; McCauley M; Rooney J; Rinehart AR; Clark J; Go V; Sugarman J; Fields SD; Adeyeye A; Grinsztejn B; Landovitz RJ; Safren SA;
    J Int AIDS Soc; 2024 May; 27(5):e26252. PubMed ID: 38783534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV burden and correlates of infection among transfeminine people and cisgender men who have sex with men in Nairobi, Kenya: an observational study.
    Smith AD; Kimani J; Kabuti R; Weatherburn P; Fearon E; Bourne A
    Lancet HIV; 2021 May; 8(5):e274-e283. PubMed ID: 33631101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injectable Pre-Exposure Prophylaxis for HIV Prevention: Perspectives on the Benefits and Barriers from Gay, Bisexual, and Queer Men and Health System Stakeholders in Ontario, Canada.
    Grace D; Gaspar M; Wells A; Sinno J; Daroya E; Montess M; Hull M; Lachowsky NJ; Tan DHS
    AIDS Patient Care STDS; 2023 Jun; 37(6):306-315. PubMed ID: 37195728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Enough: A Qualitative Study of Client Experience With Internet-Based Access to Pre-exposure Prophylaxis.
    Hughes SD; Koester KA; Engesaeth E; Hawkins MV; Grant RM
    J Med Internet Res; 2021 Jul; 23(7):e22650. PubMed ID: 36256828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Access to HIV Pre-exposure Prophylaxis in Practice Settings: a Qualitative Study of Sexual and Gender Minority Adults' Perspectives.
    Sun CJ; Anderson KM; Bangsberg D; Toevs K; Morrison D; Wells C; Clark P; Nicolaidis C
    J Gen Intern Med; 2019 Apr; 34(4):535-543. PubMed ID: 30719647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differing Experiences with Pre-Exposure Prophylaxis in Boston Among Lesbian, Gay, Bisexual, and Transgender Specialists and Generalists in Primary Care: Implications for Scale-Up.
    Krakower DS; Ware NC; Maloney KM; Wilson IB; Wong JB; Mayer KH
    AIDS Patient Care STDS; 2017 Jul; 31(7):297-304. PubMed ID: 28574774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying Community-Informed Language to Promote HIV Pre-exposure Prophylaxis (PrEP) in Black LGBTQ Communities in Baltimore.
    Fields EL; Long A; Bademosi K; Granderson R; Schumacher CM; Chandran A; Kingon Y; Jennings JM
    AIDS Educ Prev; 2020 Apr; 32(2):152-168. PubMed ID: 32539478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV pre-exposure prophylaxis programme preferences among sexually active HIV-negative transgender and gender diverse adults in the United States: a conjoint analysis.
    Watson DL; Listerud L; Drab RA; Lin WY; Momplaisir FM; Bauermeister JA
    J Int AIDS Soc; 2024 Feb; 27(2):e26211. PubMed ID: 38332521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing providers' PrEP prescription for Black cisgender women: A qualitative study to improve provider knowledge and competency via PrEP training.
    Kasal N; Devlin S; Johnson AK; Dawdani A; Enaholo OE; Liegeon G; Pyra M; Hirschhorn LR; Haider S; Ducheny K; Simon J; Ridgway JP
    Womens Health (Lond); 2024; 20():17455057241277974. PubMed ID: 39245949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief Report: "I Didn't Really Have a Primary Care Provider Until I Got PrEP": Patients' Perspectives on HIV Preexposure Prophylaxis as a Gateway to Health Care.
    Sewell WC; Powell VE; Ball-Burack M; Mayer KH; Ochoa A; Marcus JL; Krakower DS
    J Acquir Immune Defic Syndr; 2021 Sep; 88(1):31-35. PubMed ID: 34397743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weighing the Options: Which PrEP (Pre-exposure Prophylaxis) Modality Attributes Influence Choice for Young Gay and Bisexual Men in the United States?
    Hill-Rorie J; Biello KB; Quint M; Johnson B; Elopre L; Johnson K; Lillis R; Burgan K; Krakower D; Whiteside Y; Mayer KH
    AIDS Behav; 2024 Sep; 28(9):2970-2978. PubMed ID: 39126557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferences for Injectable PrEP Among Young U.S. Cisgender Men and Transgender Women and Men Who Have Sex with Men.
    Biello KB; Hosek S; Drucker MT; Belzer M; Mimiaga MJ; Marrow E; Coffey-Esquivel J; Brothers J; Mayer KH
    Arch Sex Behav; 2018 Oct; 47(7):2101-2107. PubMed ID: 28929260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing Preferences for Long-Acting Injectable Pre-Exposure Prophylaxis Among Young Adult Sexual Minority Men and Transgender Women.
    Weeden T; Garofalo R; Johnson AK; Schnall R; Cervantes M; Scherr T; Kuhns LM
    Acad Pediatr; 2024; 24(7):1110-1115. PubMed ID: 38631476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing Access to Pre-Exposure Prophylaxis Among Transgender Women and Transfeminine Nonbinary Individuals.
    Klein A; Golub SA
    AIDS Patient Care STDS; 2019 Jun; 33(6):262-269. PubMed ID: 31166785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Social Support Networks Among Young Men and Transgender Women of Color Receiving HIV Pre-Exposure Prophylaxis.
    Wood S; Dowshen N; Bauermeister JA; Lalley-Chareczko L; Franklin J; Petsis D; Swyryn M; Barnett K; Weissman GE; Koenig HC; Gross R
    J Adolesc Health; 2020 Mar; 66(3):268-274. PubMed ID: 31672523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High risk and low uptake of pre-exposure prophylaxis to prevent HIV acquisition in a national online sample of transgender men who have sex with men in the United States.
    Reisner SL; Moore CS; Asquith A; Pardee DJ; Sarvet A; Mayer G; Mayer KH
    J Int AIDS Soc; 2019 Sep; 22(9):e25391. PubMed ID: 31536171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To switch or not to switch: Intentions to switch to injectable PrEP among gay and bisexual men with at least twelve months oral PrEP experience.
    Meyers K; Wu Y; Brill A; Sandfort T; Golub SA
    PLoS One; 2018; 13(7):e0200296. PubMed ID: 30024903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17-24 years old.
    John SA; Zapata JP; Dang M; Pleuhs B; O'Neil A; Hirshfield S; Walsh JL; Petroll AE; Quinn KG
    Sci Rep; 2023 Mar; 13(1):5116. PubMed ID: 36991027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Willingness to use and preferences for long-acting injectable PrEP among sexual and gender minority populations in the southern United States, 2021-2022: cross-sectional study.
    Schoenberg P; Edwards OW; Merrill L; Martinez CA; Stephenson R; Sullivan PS; Jones J
    J Int AIDS Soc; 2023 Mar; 26(3):e26077. PubMed ID: 36951057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.